CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 779726-779924 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T66913","span":{"begin":0,"end":198},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The ALK FISH-positive lung cancer patient responded to crizotinib and then developed the well characterized ALK F1174C resistance mutation, confirming the presence of a productive ALK rearrangement."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T340","span":{"begin":0,"end":198},"obj":"Sentence"}],"text":"The ALK FISH-positive lung cancer patient responded to crizotinib and then developed the well characterized ALK F1174C resistance mutation, confirming the presence of a productive ALK rearrangement."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1689","span":{"begin":22,"end":33},"obj":"Phenotype"}],"attributes":[{"id":"A1689","pred":"hp_id","subj":"T1689","obj":"http://purl.obolibrary.org/obo/HP_0100526"}],"text":"The ALK FISH-positive lung cancer patient responded to crizotinib and then developed the well characterized ALK F1174C resistance mutation, confirming the presence of a productive ALK rearrangement."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T722","span":{"begin":22,"end":26},"obj":"Body_part"}],"attributes":[{"id":"A722","pred":"uberon_id","subj":"T722","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"The ALK FISH-positive lung cancer patient responded to crizotinib and then developed the well characterized ALK F1174C resistance mutation, confirming the presence of a productive ALK rearrangement."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3663","span":{"begin":22,"end":33},"obj":"Disease"},{"id":"T3664","span":{"begin":27,"end":33},"obj":"Disease"},{"id":"T61116","span":{"begin":22,"end":33},"obj":"Disease"},{"id":"T3612","span":{"begin":27,"end":33},"obj":"Disease"}],"attributes":[{"id":"A3663","pred":"mondo_id","subj":"T3663","obj":"http://purl.obolibrary.org/obo/MONDO_0008903"},{"id":"A3664","pred":"mondo_id","subj":"T3664","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A58832","pred":"mondo_id","subj":"T61116","obj":"http://purl.obolibrary.org/obo/MONDO_0008903"},{"id":"A30853","pred":"mondo_id","subj":"T3612","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"The ALK FISH-positive lung cancer patient responded to crizotinib and then developed the well characterized ALK F1174C resistance mutation, confirming the presence of a productive ALK rearrangement."}